Personal Care Products

HENGAN INT'L

Morgan Stanley Cuts Hengan International Target Price to HKD 23, Maintains 'At-the-Market' Rating

Citi Cuts Hengan International Earnings Forecast and Target Price, Maintains Neutral Rating

Hengan International repurchased 680,000 shares for about HKD 18.0408 million

Hengan International Releases Annual Report, Emphasizing Strong Market Performance and Strategies

Hengan International Announces 2025 Earnings Report

UBS Raises Target Price for Hengan International to HKD34.9

HENGAN INT'L released FY2025 9 Months earnings on March 17 (BJT), actual revenue HKD 18.94 B, actual EPS HKD 1.8634

HENGAN INT'L released FY2025 Q3 earnings on March 17, 2026 (BJT) with actual revenue of HKD 6.155 B and actual EPS of HKD 0.558

HENGAN INT'L released FY2025 Q4 earnings on March 17 During-Market (BJT), actual revenue HKD 6.261 B, actual EPS HKD 0.5676

HENGAN INT'L released FY2025 earnings on March 17 During-Market (BJT), actual revenue HKD 25.21 B (forecast HKD 25.44 B), actual EPS HKD 2.434 (forecast HKD 2.263)

HENGAN INT'L to Release FY2025 Earnings on March 17 During-Market (BJT), Forecast Revenue HKD 25.88 B, EPS HKD 2.302

BOA Securities Expects Hengan International to See 1% Revenue Growth in H2 2025 and Raises Target Price

Morgan Stanley Raises Revenue and Net Profit Projections for Hengan International

Xu Qingliu 增持恒安国际 50 万股

CEO of Hengan International Xu Qingliu Increases Holdings

Hengan International Completes the Issuance of a 1.8% Rate RMB 1 Billion Bond with a Term of 1 Year

Citi Raises Predicted Earnings and Target Price for Hengan International 2025-2027

Konka International Donates 6 Million Yuan to Support Tai Po Hung Fuk Estate

Xu Qingchi increased holdings in Hengan International

Xu Qingliu 增持恒安国际 20 万股

SINOFORTUNE FIN

I-CABLE COMM

CENTURY LEGEND

GOLDENSOLAR

HUASHENG INTL

TEAMWAY INTL GP

ZHONGKE GROUP

WEILI HOLDINGS

QIANHAI HEALTH

Asymchem

01044

Hengan International Group updated its board composition, appointing Mr. Sze Man Bok as chairman and Mr. Hui Ching Lau as CEO and acting chairman. The company also clarified membership for five key committees to enhance governance. Meanwhile, analysts maintain a 'Hold' rating on the stock (HK:1044) with a HK$26.00 price target.

Tip Ranks

Hengan International Updates Board Roles and Committee Structure

Hengan International filed an updated board list with the Hong Kong Stock Exchange dated June 23, 2026. Hui Ching Lau was named CEO and acting chairman, while Sze Man Bok remains executive director and chairman on leave. The board includes three other executive directors, one non-executive director, and four independent non-executive directors. Committee chairmanships were also detailed, with Hui leading ESG, Wong audit, Marin remuneration and share incentives, and Ho Kwai Ching Mark nomination.

PUBT

HKEX

HKEX-R

Hong Kong Exchanges and Clearing (HKEX)

Hengan International files directors list with Hong Kong Stock Exchange

Hengan International Group appointed CEO Hui Ching Lau as acting chairman effective June 23, 2026, while Chairman Sze Man Bok takes health-related leave. Hui retains his CEO role and brings over 24 years of management experience.

QINQIN FOODS

Hengan names CEO Hui Ching Lau acting chairman as Sze Man Bok takes health leave

Citi cut Hengan International's target price to HKD24.3 from HKD28.2, maintaining a Neutral rating, citing weak sales in the first five months due to price competition. The bank lowered earnings forecasts for 2026-2028 by 16%-20%. Rising petrochemical costs from Middle East tensions, reduced government subsidies, and adverse forex factors are expected to pressure net profit margins.

AASTOCKS News

Citigroup

CITIGROUP INC 6.250 NON CUM SER II PFD WI

Citi Cuts HENGAN INT'L  TP to HKD24.3, Maintains Neutral

Hengan Internationalannounced that Chairman Sze Man Bok is taking a temporary leave due to personal health reasons. The company's daily management, strategic execution, and operational decisions will continue to be handled seamlessly by the established executive management team.

HENGAN INTL Chairman Takes Temporary Leave Due to Personal Health Reasons

Hengan International Group Co (HK:1044) has corrected a clerical error in its 2025 annual report regarding the earnings per share unit, which should be in renminbi yuan instead of renminbi cents. The company confirmed that this amendment is purely presentational and does not affect previously reported financial results. The board aims to ensure transparency in shareholder communications. The latest analyst rating for Hengan stock is a Hold with a price target of HK$26.00, and the company operates in the consumer goods sector, focusing on personal hygiene and household paper products.

Hengan Corrects Earnings Per Share Unit in 2025 Annual Report

Hengan International Group Co has scheduled its annual general meeting for May 18, 2026, in Hong Kong. Shareholders will vote on a proposed final dividend, re-election of directors, auditor re-appointment, and a resolution to repurchase up to 10% of issued shares. This move aims to enhance capital management and signal confidence in the company's outlook. The stock currently holds a 'Hold' rating with a price target of HK$26.00. Hengan operates in the consumer goods sector, focusing on hygiene and household products in Greater China and Asia.

Hengan Sets 2026 AGM to Vote on Dividend, Director Slate and Share Buyback Mandate

Hengan International Group Co has proposed to reassign Xu Wenmo from executive director to non-executive director, effective after his re-election on May 18, 2026. Xu, with over 37 years of experience in consumer products, will receive an annual director’s fee of HK$60,000. This change reflects a shift from daily executive duties while maintaining his strategic involvement and aligning his interests with shareholders. The current analyst rating for Hengan International stock (HK:1044) is a Hold with a price target of HK$26.00.

Hengan International Reassigns Veteran Executive Xu Wenmo to Non-Executive Board Role

HENGAN INT'L(01044.HK)